DASH Diet
The DASH diet is a dietary pattern whose effect on blood pressure has been studied the most. The most cited work in the field is a meta-analysis of randomised studies on blood pressure reduction. Endpoints such as cognition, gut or uric acid rest on a much narrower foundation — here the open question remains.
1. What the DASH Diet Is
The DASH diet is not a substance but a dietary pattern. The name derives from the designation Dietary Approaches to Stop Hypertension, under which the pattern was tested in studies. It is investigated as an intervention in comparison to other dietary patterns, in randomised studies as well as in observational studies in which the proximity of habitual diet to the specification is recorded as a score and related to disease risk. In addition, modified variants exist that are summarised in separate review articles. For therapeutic practice the diet is therefore not a prescription of a single active substance but a specification for food selection over a longer period; implementation, not the intake of a substance, is the actual subject of every investigation.
Decisive for the understanding of all works is that no dose can be stated for a pattern. Instead, adherence is measured, that is the proximity of actual diet to the specification. It is predominantly recorded with questionnaires and scores; one review article is devoted expressly to adherence and hypertension risk. Two things follow from this. First, observational studies answer a different question from controlled intervention studies: the one shows an association, the other tests the effect under prescribed diet. Second, the pattern can also be described by metabolic profiles of the serum; an untargeted metabolomic work assigns it its own profile. Whether such profiles map adherence more objectively than questionnaires is a testable open question.
2. How Reliable the Research Is
The controlled human studies are distributed unevenly. The focus clearly lies on cardiovascular endpoints; no other area reaches this breadth. Metabolic, safety, fatigue and inflammation follow. Clearly smaller groups form antioxidant parameters, cognition, gut, oncology and immune system. Some of the frequently cited works also come from health-services research, for example on heart failure or on self-management support in hypertension; these works examine the embedding of the pattern in care, not the pattern alone. For practice it follows that statements on blood pressure rest on a broad basis, statements on cognition, gut or immune system on individual works.
Methodologically the field is well positioned: several meta-analyses of randomised studies exist, the most-cited work is such an analysis on blood pressure, and systematic reviews on metabolic risk factors in chronic diseases, on oxidative stress, on overweight in adolescents and on modified variants of the pattern stand alongside. This is the most reliable form of summary. Three points act as limitations: the endpoints are heterogeneous, adherence is usually self-reported, and some observational studies cannot separate the dietary pattern from other lifestyle factors. Basic research and one animal study complete the picture; such findings are preclinical and carry no statement about application in humans.
Distribution of controlled human studies by application area — the numbers are not additive because one work can be assigned to several areas:
| Application area | controlled studies |
|---|---|
| Heart and circulation | 100 |
| Metabolism | 56 |
| Safety and tolerability | 16 |
| Fatigue and stress | 14 |
| Inflammatory processes | 13 |
| Oxidative stress | 7 |
| Cognition and psyche | 7 |
| Gut and microbiome | 5 |
3. What Is Frequently Claimed — and What the Data Provide
| Claim | Study situation |
|---|---|
| Blood pressure in hypertension | A meta-analytical summary of randomised studies supports the blood pressure-lowering effect in adults with and without hypertension; a controlled study also exists in adolescents with elevated values. This is the best-supported endpoint in the field. |
| Weight and metabolic risk | Systematic reviews and meta-analyses examine metabolic risk factors in chronic diseases and overweight in adolescents. They contribute summarily; individual endpoints such as uric acid are only tested in individual randomised evaluations. |
| Cognition and exhaustion | Few controlled studies are available in both areas. A frequently cited randomised study on lifestyle and neurocognition does not examine a DASH programme alone and therefore cannot be attributed to the pattern. |
| Periodontitis | The association between dietary patterns and periodontitis originates from a cross-sectional study. A cross-sectional study shows concurrent associations and cannot demonstrate an effect of the pattern. |
4. The Most Robust Studies
Ordered by strength of evidence, not by familiarity: reviews and studies with many participants first. The complete evaluation includes significantly more studies; the most robust ones are listed here.
Controlled Studies in Humans
- 1 Dietary Approaches to Stop Hypertension (DASH) Diet and Blood Pressure Reduction in Adults with and without Hypertension: A Systematic Review and … (2020) — Übersichtsarbeit, 5.545 Teilnehmer
- 2 Adherence to the Dietary Approaches to Stop Hypertension diet reduces the risk of breast cancer: A systematic review and meta-analysis (2022) — Übersichtsarbeit, 449.273 Teilnehmer
- 3 Adherence to the dietary approaches to stop hypertension diet reduces the risk of diabetes mellitus: a systematic review and dose-response … (2024) — Übersichtsarbeit, 557.475 Teilnehmer
- 4 Effect of Dietary Approaches to Stop Hypertension (DASH) diet on lipid profile in individuals with overweight/ obesity: A GRADE-assessed systematic … (2025) — Übersichtsarbeit, 3.562 Teilnehmer
- 5 Digital-Based Nutrition Interventions Employing the Dietary Approaches to Stop Hypertension (DASH) Diet: A Systematic Scoping Review (2025) — Übersichtsarbeit, 7.000 Teilnehmer
- 6 The effect of DASH diet on components of metabolic syndrome: a systematic review and meta-analysis of randomized controlled trials (2026) — Übersichtsarbeit, 1.062 Teilnehmer
- 7 Adherence to the Dietary Approaches to Stop Hypertension diet reduces the risk of diabetes mellitus: A systematic review and dose-response … (2024) — Übersichtsarbeit, 557.475 Teilnehmer
- 8 Effect of DASH diet on oxidative stress parameters: A systematic review and meta-analysis of randomized clinical trials (2020) — Übersichtsarbeit, 317 Teilnehmer
- 9 Evaluating the impact of the Dietary Approaches to Stop Hypertension diet versus a calorie-restricted diet on metabolic dysfunction-associated … (2025) — Übersichtsarbeit, 280 Teilnehmer
- 10 The effects of the Dietary Approaches to Stop Hypertension (DASH) diet on metabolic risk factors in patients with chronic disease: A systematic … (2021) — Übersichtsarbeit
- 11 Effects of the Dietary Approach to Stop Hypertension (DASH) diet on blood pressure, overweight and obesity in adolescents: A systematic review (2018) — Übersichtsarbeit
- 12 Effects of the Modified DASH Diet on Adults With Elevated Blood Pressure or Hypertension: A Systematic Review and Meta-Analysis (2021) — Übersichtsarbeit
- 13 Effects of the Dietary Approaches to Stop Hypertension (DASH) on Pregnancy/Neonatal Outcomes and Maternal Glycemic Control: A Systematic Review and … (2020) — Übersichtsarbeit
- 14 Dietary Approaches to Stop Hypertension (DASH) diet and mental well-being: a systematic review (2023) — Übersichtsarbeit
- Effect of dietary patterns on functional dyspepsia in adults: a systematic review (2025) — Systematic review
- 15 The Effect of Dietary Approaches to Stop Hypertension (DASH) Diet on Liver Enzyme Level in Adults: A GRADE-Assessed Systematic Review and … (2025) — Systematic review
- Association between Dietary Pattern and Periodontitis-A Cross-Sectional Study (2021) — 6.209 participants
- 16 Dietary Approaches to Stop Hypertension (DASH) Score and Its Association with Sleep Quality in a National Survey of Middle-Aged and Older Men and … (2020) — 3.941 participants
- 17 DASH (Dietary Approaches to Stop Hypertension) dietary pattern and maternal blood pressure in pregnancy (2020) — 511 participants
- 18 A Tailored Behavioral Intervention to Promote Adherence to the DASH Diet (2019) — 533 participants
- 19 Dietary Approaches to Stop Hypertension (DASH) for the primary and secondary prevention of cardiovascular diseases (2025) — 1.397 participants
- 20 Compliance with the DASH diet and risk of all-cause and cardiovascular mortality in patients with myocardial infarction (2023) — 4.365 participants
- 21 Short-term effect of modest salt reduction combined with the CM-DASH diet on salt eating habits in hypertensive patients with type II diabetes: A … (2021) — 3.114 participants
- 22 Serum untargeted metabolomic profile of the Dietary Approaches to Stop Hypertension (DASH) dietary pattern (2018) — 329 participants
5. Summary
Proven After several consistent randomised studies and their meta-analytical summary, the blood pressure-lowering effect is the best-established endpoint in the field; the most-cited work is a meta-analysis of randomised controlled trials in adults with and without hypertension (study 1, 5.545 participants). A controlled study also exists in adolescents with elevated values. The focus of controlled human research lies clearly on cardiovascular endpoints; no other area achieves this breadth. Everything else has been examined less, but not refuted.
Plausible Reviews exist on oxidative stress, individual randomised evaluations on uric acid and vascular risk, and systematic reviews on metabolic risk factors in chronic diseases and on overweight in adolescents. Hypothesis: Some attributions derive from frequently cited works that do not test the pattern in isolation, such as a randomised study on a blood-pressure app or a study on lifestyle and neurocognition; the proportion of a result that actually depends on the pattern would need to be clarified in a dedicated study.
The first point to clarify would be adherence measurement: which measure maps actual nutrition so that observational and interventional studies become comparable? In controlled studies nutrition is prescribed; there the result carries more weight but transfers less readily to everyday life; observational studies show an association, not a tested effect. For cognition a randomised study is lacking that tests the pattern alone, with sufficient duration and a clinically relevant cognitive endpoint. It also remains open whether adherence and effect can be objectively mapped via serum metabolites and whether these markers agree with the questionnaire values.
6. What Remains Open
- Adherence: Which measure maps actual nutrition so that observational and interventional studies become comparable?
- Cognition: Which randomised study tests the pattern alone, with sufficient duration and a clinically relevant cognitive endpoint?
- Metabolic profiles: Can adherence and effect be objectively mapped via serum metabolites, and do these markers agree with the questionnaire values?
Frequently Asked Questions
How do I distinguish between observation and tested effect with the DASH diet?
Observational studies assign an adherence score to disease risk; they show an association into which other lifestyle factors also enter. Controlled studies prescribe the diet and test the effect. For blood pressure there is additionally a meta-analytical summary of randomised studies; for most other endpoints this synthesis is still pending.
What can be measured additionally when there is no dose concept?
A pattern cannot be stated in milligrams. What can be measured is proximity to the specification, that is adherence, and the endpoints themselves, for example blood pressure and metabolic values. Adherence is predominantly self-reported, which limits its informative value. Serum profiles could supply a more objective measure in future; as routine parameters they are not yet established.
What has been tested in people with chronic disease?
Systematic reviews and meta-analyses are available on this question that examine metabolic risk factors in chronic diseases, as well as studies on heart failure and on type 2 diabetes with prehypertension. These reviews pool heterogeneous studies; which patient group responds to what extent cannot be derived from them and remains an open question.
Sources
- 1Filippou CD, Tsioufis CP, Thomopoulos CG, Mihas CC, Dimitriadis KS, Sotiropoulou LI et al. · 2020
- 2Shu L, Huang YQ, Zhang XY, Zheng PF, Zhu Q, Zhou JY · 2022
- 3Quan X, Shen X, Li C, Li Y, Li T, Chen B · 2024
- 4Zare P, Bideshki MV, Sohrabi Z, Behzadi M, Sartang MM · 2025
- 5Dodge E, Kelly PJ, Aboul-Enein BH · 2025
- 6Zhao P, Fu W, Cui L, Lin L · 2026
- 7Quan X, Shen X, Li C, Li Y, Li T, Chen B · 2024
- 8Pirouzeh R, Heidarzadeh-Esfahani N, Morvaridzadeh M, Izadi A, Yosaee S, Potter E et al. · 2020
- 9Hasan F, Singh A, Garcia A, Qadri SH, Sattar H, Ali R et al. · 2025
- 10Lari A, Sohouli MH, Fatahi S, Cerqueira HS, Santos HO, Pourrajab B et al. · 2021
- 11Paula Bricarello L, Poltronieri F, Fernandes R, Retondario A, de Moraes Trindade EBS, de Vasconcelos FAG · 2018
- 12Guo R, Li N, Yang R, Liao XY, Zhang Y, Zhu BF et al. · 2021
- 13Li S, Gan Y, Chen M, Wang M, Wang X, O Santos H et al. · 2020
- 14Tan J, Wang C, Tomiyama AJ · 2023
- 15Mohtashamian A, Aali Y, Nematolahi F, Ebrahimzadeh A, Ferns GA, Ghayour-Mobarhan M · 2025
- 16Liang H, Beydoun HA, Hossain S, Maldonado A, Zonderman AB, Fanelli-Kuczmarski MT et al. · 2020
- 17Courtney AU, O'Brien EC, Crowley RK, Geraghty AA, Brady MB, Kilbane MT et al. · 2020
- 18Rodriguez MA, Friedberg JP, DiGiovanni A, Wang B, Wylie-Rosett J, Hyoung S et al. · 2019
- 19Bensaaud A, Seery S, Gibson I, Jones J, Flaherty G, McEvoy JW et al. · 2025
- 20Bonekamp NE, Cruijsen E, Visseren FL, van der Schouw YT, Geleijnse JM, Koopal C · 2023
- 21Chen D, Tang J, Gong T, Mu L, Li J, Yu P et al. · 2021
- 22Rebholz CM, Lichtenstein AH, Zheng Z, Appel LJ, Coresh J · 2018
Every statement on this page carries its evidence tier — proven, plausible or hypothesis — and leads to the original work. The decision in the individual case rests with the practitioner; we provide the connections.